nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP1A2—chronic obstructive pulmonary disease	0.59	1	CbGaD
Nitric Oxide—CYP1A2—Aminophylline—chronic obstructive pulmonary disease	0.0578	0.257	CbGbCtD
Nitric Oxide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.047	0.209	CbGbCtD
Nitric Oxide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0317	0.141	CbGbCtD
Nitric Oxide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0303	0.135	CbGbCtD
Nitric Oxide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.027	0.12	CbGbCtD
Nitric Oxide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.0158	0.0705	CbGbCtD
Nitric Oxide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.0149	0.0666	CbGbCtD
Nitric Oxide—Cerebral infarction—Arformoterol—chronic obstructive pulmonary disease	0.00596	0.0909	CcSEcCtD
Nitric Oxide—Cerebral infarction—Formoterol—chronic obstructive pulmonary disease	0.00596	0.0909	CcSEcCtD
Nitric Oxide—Dry throat—Salbutamol—chronic obstructive pulmonary disease	0.00447	0.0682	CcSEcCtD
Nitric Oxide—ALDH2—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00345	0.0427	CbGpPWpGaD
Nitric Oxide—GUCY1A3—respiratory system—chronic obstructive pulmonary disease	0.00308	0.0798	CbGeAlD
Nitric Oxide—GUCY1B3—respiratory system—chronic obstructive pulmonary disease	0.00306	0.0792	CbGeAlD
Nitric Oxide—GUCY1A2—lung—chronic obstructive pulmonary disease	0.0026	0.0673	CbGeAlD
Nitric Oxide—ALDH2—respiratory system—chronic obstructive pulmonary disease	0.0026	0.0673	CbGeAlD
Nitric Oxide—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00255	0.0316	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00255	0.0316	CbGpPWpGaD
Nitric Oxide—GUCY1A3—bronchus—chronic obstructive pulmonary disease	0.00254	0.0657	CbGeAlD
Nitric Oxide—GUCY1B3—bronchus—chronic obstructive pulmonary disease	0.00252	0.0652	CbGeAlD
Nitric Oxide—CYP1A2—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00252	0.0311	CbGpPWpGaD
Nitric Oxide—ALDH2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00251	0.031	CbGpPWpGaD
Nitric Oxide—ALDH2—connective tissue—chronic obstructive pulmonary disease	0.00229	0.0592	CbGeAlD
Nitric Oxide—GUCY1A3—trachea—chronic obstructive pulmonary disease	0.00228	0.059	CbGeAlD
Nitric Oxide—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS2—chronic obstructive pulmonary disease	0.00228	0.0281	CbGpPWpGaD
Nitric Oxide—GUCY1B3—trachea—chronic obstructive pulmonary disease	0.00226	0.0586	CbGeAlD
Nitric Oxide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0022	0.0272	CbGpPWpGaD
Nitric Oxide—ALDH2—bronchus—chronic obstructive pulmonary disease	0.00214	0.0554	CbGeAlD
Nitric Oxide—ALDH2—smooth muscle tissue—chronic obstructive pulmonary disease	0.00209	0.0542	CbGeAlD
Nitric Oxide—Chest discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.0316	CcSEcCtD
Nitric Oxide—GUCY1B3—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00205	0.0254	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00205	0.0254	CbGpPWpGaD
Nitric Oxide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	0.00194	0.024	CbGpPWpGaD
Nitric Oxide—ALDH2—trachea—chronic obstructive pulmonary disease	0.00192	0.0497	CbGeAlD
Nitric Oxide—GUCY1A3—Nitric oxide stimulates guanylate cyclase—NOS3—chronic obstructive pulmonary disease	0.00183	0.0226	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00179	0.0272	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00173	0.0264	CcSEcCtD
Nitric Oxide—GUCY1A3—lung—chronic obstructive pulmonary disease	0.00164	0.0424	CbGeAlD
Nitric Oxide—GUCY1B3—lung—chronic obstructive pulmonary disease	0.00163	0.0421	CbGeAlD
Nitric Oxide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	0.00159	0.0196	CbGpPWpGaD
Nitric Oxide—ALDH2—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00148	0.0183	CbGpPWpGaD
Nitric Oxide—ALDH2—lung—chronic obstructive pulmonary disease	0.00138	0.0357	CbGeAlD
Nitric Oxide—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.0204	CcSEcCtD
Nitric Oxide—CYP1A2—respiratory system—chronic obstructive pulmonary disease	0.00122	0.0315	CbGeAlD
Nitric Oxide—CYP2B6—respiratory system—chronic obstructive pulmonary disease	0.00117	0.0302	CbGeAlD
Nitric Oxide—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.0167	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00109	0.0166	CcSEcCtD
Nitric Oxide—ALDH2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00108	0.0133	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000995	0.0123	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000995	0.0123	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000983	0.0121	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000983	0.0121	CbGpPWpGaD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000973	0.012	CbGpPWpGaD
Nitric Oxide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000967	0.0147	CcSEcCtD
Nitric Oxide—CYP2B6—bronchus—chronic obstructive pulmonary disease	0.00096	0.0248	CbGeAlD
Nitric Oxide—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000926	0.0141	CcSEcCtD
Nitric Oxide—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000922	0.0141	CcSEcCtD
Nitric Oxide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000906	0.0138	CcSEcCtD
Nitric Oxide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000906	0.0138	CcSEcCtD
Nitric Oxide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000904	0.0138	CcSEcCtD
Nitric Oxide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000897	0.0137	CcSEcCtD
Nitric Oxide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000896	0.0137	CcSEcCtD
Nitric Oxide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000894	0.0136	CcSEcCtD
Nitric Oxide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000887	0.0135	CcSEcCtD
Nitric Oxide—GUCY1A3—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000887	0.011	CbGpPWpGaD
Nitric Oxide—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00088	0.0134	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00088	0.0134	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000876	0.0108	CbGpPWpGaD
Nitric Oxide—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000862	0.0131	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000859	0.0106	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000859	0.0106	CbGpPWpGaD
Nitric Oxide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000856	0.013	CcSEcCtD
Nitric Oxide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000855	0.013	CcSEcCtD
Nitric Oxide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000852	0.013	CcSEcCtD
Nitric Oxide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000845	0.0129	CcSEcCtD
Nitric Oxide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000843	0.0128	CcSEcCtD
Nitric Oxide—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.0127	CcSEcCtD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.000836	0.0103	CbGpPWpGaD
Nitric Oxide—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000831	0.0127	CcSEcCtD
Nitric Oxide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000807	0.00997	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000802	0.0099	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.0008	0.00988	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.0008	0.00988	CbGpPWpGaD
Nitric Oxide—CYP2B6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000767	0.00947	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000766	0.00946	CbGpPWpGaD
Nitric Oxide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.011	CcSEcCtD
Nitric Oxide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000723	0.011	CcSEcCtD
Nitric Oxide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000721	0.011	CcSEcCtD
Nitric Oxide—GUCY1A3—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000713	0.00881	CbGpPWpGaD
Nitric Oxide—ALDH2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000707	0.00873	CbGpPWpGaD
Nitric Oxide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.0104	CcSEcCtD
Nitric Oxide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000683	0.00844	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.000681	0.00841	CbGpPWpGaD
Nitric Oxide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00068	0.0104	CcSEcCtD
Nitric Oxide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00068	0.0104	CcSEcCtD
Nitric Oxide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000666	0.0102	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000665	0.0101	CcSEcCtD
Nitric Oxide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000648	0.00988	CcSEcCtD
Nitric Oxide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000648	0.00988	CcSEcCtD
Nitric Oxide—CYP1A2—lung—chronic obstructive pulmonary disease	0.000646	0.0167	CbGeAlD
Nitric Oxide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00982	CcSEcCtD
Nitric Oxide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000642	0.00979	CcSEcCtD
Nitric Oxide—ALDH2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00064	0.00791	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000622	0.00768	CbGpPWpGaD
Nitric Oxide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000622	0.00768	CbGpPWpGaD
Nitric Oxide—CYP2B6—lung—chronic obstructive pulmonary disease	0.00062	0.016	CbGeAlD
Nitric Oxide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	0.000619	0.00764	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.00943	CcSEcCtD
Nitric Oxide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000618	0.00943	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000614	0.00759	CbGpPWpGaD
Nitric Oxide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000612	0.00933	CcSEcCtD
Nitric Oxide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000603	0.00919	CcSEcCtD
Nitric Oxide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.0089	CcSEcCtD
Nitric Oxide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000571	0.0087	CcSEcCtD
Nitric Oxide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000568	0.00866	CcSEcCtD
Nitric Oxide—CYP2B6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000557	0.00688	CbGpPWpGaD
Nitric Oxide—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000555	0.00847	CcSEcCtD
Nitric Oxide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000538	0.00821	CcSEcCtD
Nitric Oxide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.0082	CcSEcCtD
Nitric Oxide—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000531	0.0081	CcSEcCtD
Nitric Oxide—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000529	0.00806	CcSEcCtD
Nitric Oxide—ALDH2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000522	0.00645	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000517	0.00638	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000502	0.0062	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000493	0.00609	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000493	0.00609	CbGpPWpGaD
Nitric Oxide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00048	0.00593	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000463	0.00572	CbGpPWpGaD
Nitric Oxide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000459	0.00699	CcSEcCtD
Nitric Oxide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000459	0.00699	CcSEcCtD
Nitric Oxide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000449	0.00685	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00044	0.00543	CbGpPWpGaD
Nitric Oxide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000434	0.00662	CcSEcCtD
Nitric Oxide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000434	0.00662	CcSEcCtD
Nitric Oxide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000433	0.0066	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000431	0.00532	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000428	0.00528	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000428	0.00528	CbGpPWpGaD
Nitric Oxide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00649	CcSEcCtD
Nitric Oxide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.000417	0.00515	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.000412	0.00508	CbGpPWpGaD
Nitric Oxide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00041	0.00625	CcSEcCtD
Nitric Oxide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000399	0.00608	CcSEcCtD
Nitric Oxide—ALDH2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000396	0.00489	CbGpPWpGaD
Nitric Oxide—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000392	0.00485	CbGpPWpGaD
Nitric Oxide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000391	0.00596	CcSEcCtD
Nitric Oxide—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000386	0.00589	CcSEcCtD
Nitric Oxide—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000384	0.00586	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000384	0.00474	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000384	0.00474	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000381	0.00471	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000379	0.00468	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000377	0.00465	CbGpPWpGaD
Nitric Oxide—ALDH2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000375	0.00464	CbGpPWpGaD
Nitric Oxide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00037	0.00563	CcSEcCtD
Nitric Oxide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	0.000363	0.00449	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000357	0.00441	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.00035	0.00433	CbGpPWpGaD
Nitric Oxide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000349	0.00531	CcSEcCtD
Nitric Oxide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000349	0.00431	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000346	0.00427	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000346	0.00427	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000342	0.00422	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000335	0.00414	CbGpPWpGaD
Nitric Oxide—CYP1A2—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000328	0.00405	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000326	0.00402	CbGpPWpGaD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000319	0.00393	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000316	0.0039	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000314	0.00388	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000308	0.00381	CbGpPWpGaD
Nitric Oxide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.000303	0.00374	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000302	0.00373	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.000291	0.00359	CbGpPWpGaD
Nitric Oxide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00029	0.00442	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000276	0.00341	CbGpPWpGaD
Nitric Oxide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000276	0.0034	CbGpPWpGaD
Nitric Oxide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00409	CcSEcCtD
Nitric Oxide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000268	0.00408	CcSEcCtD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.00026	0.00321	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000258	0.00319	CbGpPWpGaD
Nitric Oxide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000253	0.00313	CbGpPWpGaD
Nitric Oxide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000248	0.00379	CcSEcCtD
Nitric Oxide—GUCY1B3—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000247	0.00305	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000247	0.00305	CbGpPWpGaD
Nitric Oxide—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.00301	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000244	0.00301	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000243	0.003	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000243	0.003	CbGpPWpGaD
Nitric Oxide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.00359	CcSEcCtD
Nitric Oxide—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000231	0.00286	CbGpPWpGaD
Nitric Oxide—CYP2B6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000228	0.00282	CbGpPWpGaD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000228	0.00282	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000223	0.00275	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000223	0.00275	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00022	0.00272	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000216	0.00267	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000205	0.00253	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0002	0.00247	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000199	0.00245	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GC—chronic obstructive pulmonary disease	0.000195	0.0024	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000192	0.00237	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000188	0.00232	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000188	0.00232	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000188	0.00232	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000187	0.00231	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000187	0.00231	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000181	0.00223	CbGpPWpGaD
Nitric Oxide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00275	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000179	0.00221	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000179	0.00221	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000179	0.00221	CbGpPWpGaD
Nitric Oxide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000171	0.00261	CcSEcCtD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00208	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00208	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000169	0.00208	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000167	0.00207	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000167	0.00206	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.000166	0.00205	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000165	0.00204	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.000164	0.00203	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000163	0.00201	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.00016	0.00197	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000158	0.00195	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000148	0.00183	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000145	0.00179	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000143	0.00176	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000137	0.00169	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00168	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000135	0.00167	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.00166	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00013	0.00161	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000129	0.00159	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000129	0.00159	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000119	0.00146	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000119	0.00146	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000117	0.00145	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000115	0.00142	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000115	0.00142	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000114	0.00141	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000113	0.00139	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00011	0.00136	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000106	0.00131	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000106	0.00131	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000106	0.0013	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000105	0.0013	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000105	0.0013	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000105	0.0013	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000104	0.00128	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000104	0.00128	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	9.97e-05	0.00123	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	9.83e-05	0.00121	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—chronic obstructive pulmonary disease	9.76e-05	0.00121	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—chronic obstructive pulmonary disease	9.76e-05	0.00121	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	9.72e-05	0.0012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GCLC—chronic obstructive pulmonary disease	9.61e-05	0.00119	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CTGF—chronic obstructive pulmonary disease	9.59e-05	0.00118	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	9.32e-05	0.00115	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.83e-05	0.00109	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—chronic obstructive pulmonary disease	8.7e-05	0.00107	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	8.53e-05	0.00105	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—APIP—chronic obstructive pulmonary disease	8.02e-05	0.00099	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.89e-05	0.000975	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	7.5e-05	0.000926	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	7.41e-05	0.000916	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.37e-05	0.00091	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.27e-05	0.000898	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	7.25e-05	0.000895	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	7.1e-05	0.000878	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	7.1e-05	0.000878	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	6.83e-05	0.000844	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.77e-05	0.000836	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	6.77e-05	0.000836	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.77e-05	0.000836	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	6.74e-05	0.000832	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	6.64e-05	0.00082	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.42e-05	0.000793	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.23e-05	0.00077	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	6.19e-05	0.000765	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.15e-05	0.000759	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	6.1e-05	0.000754	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	5.87e-05	0.000725	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	5.79e-05	0.000715	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.31e-05	0.000656	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.2e-05	0.000642	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GC—chronic obstructive pulmonary disease	5.17e-05	0.000638	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.13e-05	0.000633	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.8e-05	0.000593	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	4.78e-05	0.00059	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—APIP—chronic obstructive pulmonary disease	4.72e-05	0.000583	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	4.71e-05	0.000582	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.53e-05	0.000559	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.47e-05	0.000552	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ALB—chronic obstructive pulmonary disease	4.36e-05	0.000539	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NOS3—chronic obstructive pulmonary disease	4.17e-05	0.000516	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.64e-05	0.00045	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	3.37e-05	0.000416	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.13e-05	0.000386	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GC—chronic obstructive pulmonary disease	3.04e-05	0.000376	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.83e-05	0.000349	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.82e-05	0.000349	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.79e-05	0.000345	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.55e-05	0.000314	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.41e-05	0.000298	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.35e-05	0.00029	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.35e-05	0.00029	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.25e-05	0.000278	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.18e-05	0.00027	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.96e-05	0.000242	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.93e-05	0.000238	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.8e-05	0.000222	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.7e-05	0.00021	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.66e-05	0.000205	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.64e-05	0.000203	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.53e-05	0.000189	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.5e-05	0.000185	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000158	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.27e-05	0.000157	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ALB—chronic obstructive pulmonary disease	1.16e-05	0.000143	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.16e-05	0.000143	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.15e-05	0.000142	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.14e-05	0.00014	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.11e-05	0.000137	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.07e-05	0.000132	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.06e-05	0.000131	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1e-05	0.000124	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.89e-06	0.00011	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.77e-06	0.000108	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.17e-06	0.000101	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.74e-06	9.57e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.82e-06	8.42e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.52e-06	8.06e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.26e-06	6.5e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.04e-06	6.22e-05	CbGpPWpGaD
